27 studies found for:    " July 16, 2008":" August 15, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Lovastatin: Immunomodulatory Value Evaluation
Condition: HIV Seropositivity
Interventions: Drug: Lovastatin;   Other: placebo
2 Completed Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo
3 Completed
Has Results
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Condition: HIV Infection
Interventions: Drug: Placebo;   Drug: Maraviroc
4 Completed The Effect of Vitamin D and Calcium on Bone in Pediatric HIV
Conditions: HIV Infection;   Bone Mass
Intervention: Dietary Supplement: cholecalciferol plus calcium carbonate
5 Completed GSK706769/KALETRA Drug-drug Interaction Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769 & KALETRA
6 Completed
Has Results
Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF);   Drug: abacavir (ABC)/lamivudine (3TC)
7 Unknown  Women-Focused HIV Prevention in the Western Cape
Conditions: HIV;   Substance Abuse;   Violence
Interventions: Behavioral: Woman-Focused Intervention (Women's CoOp);   Behavioral: Nutrition (Attention-Control);   Behavioral: VCT Only
8 Completed TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Conditions: HIV;   AIDS;   Hepatic Impairment
Intervention: Drug: TMC278
9 Unknown  Online Social Networking for HIV Prevention
Condition: HIV
Intervention: Behavioral: Online social networking HIV prevention
10 Completed Pregnant Women's CoOp
Condition: HIV
Interventions: Behavioral: Woman-focused intervention;   Behavioral: Treatment as Usual
11 Completed Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Conditions: HIV/AIDS;   Drug Abuse;   Alcohol Abuse
Intervention: Behavioral: Cognitive Behavioral Stress Management
12 Completed
Has Results
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
Conditions: HIV Infections;   Fatigue
Interventions: Drug: Armodafinil;   Drug: Placebo
13 Completed
Has Results
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PEG-IFN alfa-2b;   Drug: RBV
14 Completed Intervention for (Those) Recently Informed of Seropositive Status (IRISS)
Condition: HIV Infections
Interventions: Behavioral: Skills-Building Intervention;   Behavioral: Personal Interview Group
15 Completed Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: Addition of raltegravir 800 mg QD to HAART
16 Completed Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
Condition: HIV Infections
Intervention: Drug: Nevirapine and Efavirenz
17 Completed
Has Results
Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
Condition: HIV Infections
Intervention: Drug: Raltegravir
18 Completed Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families
Condition: HIV Infections
Interventions: Behavioral: Family Centered Advanced Care Planning (FCACP) sessions;   Behavioral: Health education control sessions
19 Withdrawn Maraviroc Compassionate Use
Condition: Human Immunodeficiency Virus Type 1
Intervention: Drug: Maraviroc
20 Completed
Has Results
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Efavirenz 600mg;   Drug: Boosted Lexiva

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years